In CLL patients’ cells, PRIMA-1Met alone was toxic in a concentration and time-dependent manner, with no significant difference related to the p53 status, and in agreement with the results previously reported [28]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.